Reuters logo
BRIEF-Opiant Pharmaceuticals reports Q4 loss per share $0.17‍​
October 13, 2017 / 11:38 AM / a month ago

BRIEF-Opiant Pharmaceuticals reports Q4 loss per share $0.17‍​

Oct 13 (Reuters) - Opiant Pharmaceuticals Inc

* Opiant Pharmaceuticals Inc reports fiscal fourth quarter and full year 2017 financial results and provides corporate update

* Q4 revenue $3.75 million versus $300,000

* ‍Opiant Pharmaceuticals Inc - appointed David O‘Toole as chief financial officer​

* Opiant Pharmaceuticals Inc - qtrly loss per share $0.17‍​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below